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Objective: We reviewed the Mayo Clinic experience with management and outcome of hepatic artery aneurysms (HAA).
Methods: Retrospective review of charts for 306 patients with true visceral aneurysm diagnosed from 1980 to 1998
enabled identification of 36 patients (12%) with HAA.
Results: Patients with HAA included 23 men and 13 women, with mean age of 62.2 years (range, 20-85 years). Most
aneurysms were extrahepatic (78%) and single (92%). Mean aneurysm diameter at presentation was 3.6 cm (range, 1.5-14
cm). Five aneurysms had ruptured (14%), and four were symptomatic (11%). Mortality from rupture was 40%. Of the 9
patients with ruptured or symptomatic aneurysms, 2 patients had multiple HAA, 3 patients had fibromuscular dysplasia,
and 2 patients had polyarteritis nodosa. All five HAAs that ruptured were of nonatherosclerotic origin (P  .001).
Fourteen patients (39%) underwent elective procedures, including excision with vein graft (n  7), excision with dacron
graft (n  3), excision alone (n  2), and percutaneous embolization (n  2). Two vein grafts and one dacron graft
became occluded within 1 year. Nonoperative management was elected in 22 patients (61%) with mean aneurysm
diameter 2.3 cm (range, 1.5-5 cm). No complications related to the aneurysm occurred during mean follow-up of 68.4
months (range, 1-372 months). Aneurysm growth was identified in 27%, the greatest being 0.8 cm over 34 months.
Conclusions: HAA are at definite risk for rupture (14%). Risk factors for rupture include multiple HAA and nonathero-
sclerotic origin. Patients with symptomatic aneurysms or any of these risk factors should be considered for intervention.
(J Vasc Surg 2003;38:41-5.)
Hepatic artery aneurysms (HAA) are rare and represent
approximately 20% of all visceral aneurysms.1-6 Histori-
cally, most aneurysms had ruptured at presentation or were
incidentally discovered at autopsy. The recent advances in
and rapid proliferation of cross-sectional imaging has en-
abled identification of HAA earlier in their natural history.
Over the last two decades the treatment options for rup-
tured or symptomatic HAA have evolved to include embo-
lization. However, because of the rarity of these aneurysms,
optimal management of asymptomatic HAA remains con-
troversial. The risk-benefit ratio of treating asymptomatic
HAA is difficult to assess in the absence of knowledge about
the risk factors associated with rupture. In addition, most
data available on HAA are derived from series with a small
cohort of subjects with a combination of both true and false
aneurysms.
We previously reported 12 HAA treated surgically at
Mayo Clinic Rochester between 1979 and 1991.7 In the
current study we report our experience with true HAA
managed operatively and nonoperatively at our institutions
over the last two decades.
PATIENTS AND METHODS
A retrospective review was undertaken of charts for all
patients with documented HAA seen at the Mayo Clinic
(Rochester, Minn; Scottsdale, Ariz; Jacksonville, Fla) be-
tween January 1, 1980, and December 31, 1998. The study
was reviewed and approved by our institutional review
board. Included for review were charts for patients with
HAA diagnosed with imaging studies, surgical exploration,
or autopsy evaluation. Excluded from review were charts
for patients with hepatic artery pseudoaneurysms. The
records for all patients were analyzed with regard to demo-
graphic data, comorbid conditions, clinical presentation,
aneurysm characteristics, imaging studies, management in-
cluding operative intervention, and outcome. Long-term
follow-up was obtained via chart review or by direct phone
contact of the patient or relative. No specific protocol was
followed for management of these aneurysms; surgeon
preference and judgment dictated all management deci-
sions.
The rate of atherosclerosis and of other variables of
interest, ie, nonatherosclerotic aneurysm origin, was com-
pared between two groups: ruptured versus nonruptured
aneurysms. Statistical significance was assessed with the
Fisher exact test. Margin of error was determined by gen-
erating 95% confidence intervals around the difference of
group rates.
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RESULTS
Demographic data and associated conditions. Of
306 patients with a diagnosis of visceral artery aneurysm
seen at our institutions between 1980 and 1998, 36 pa-
tients (12%) had HAA. Twenty-three patients (64%) were
men, and 13 patients (36%) were women. Mean patient age
at presentation was 62.2 years (range, 20-85 years).
Hypertension was the most common comorbid condi-
tion in patients with HAA (72%), followed by malignancy
(33%), peptic ulcer disease or gastritis (28%), coronary
artery disease (22%), peripheral vascular disease (14%),
chronic obstructive pulmonary disease (11%), and obesity
(11%). Fibromuscular dysplasia was present in 6 patients
(17%), polyarteritis nodosa in 2 patients (6%), and sclero-
derma in 1 patient (3%). Tobacco and alcohol use was
documented in 67% of patients.
Incidence of concomitant aneurysms in patients with
HAA is summarized in Table I. Nonhepatic visceral artery
aneurysms were present in 31% of patients, with splenic
artery aneurysm being the most common type (20%). Non-
visceral aneurysms were documented in 42% of patients;
abdominal aortic aneurysm occurred most frequently
(20%).
Clinical presentation and diagnosis. Twenty-seven
of 36 patients with HAA (75%) had no symptoms. Five
patients (14%), 3 men (13%) and 2 women (15%), had
ruptured HAA at presentation. Mean age of patients with
ruptured aneurysms was 57.6 years (range, 20-85 years). In
the group with ruptured aneurysms, 2 patients each had
multiple hepatic aneurysms, polyarteritis nodosa, or fibro-
muscular dysplasia, and 1 patient had a history of endocar-
ditis; 3 patients in this group had concomitant nonhepatic
aneurysms. All five ruptured aneurysms were of nonathero-
sclerotic origin. Rupture did not occur in the 26 patients
with atherosclerotic HAA (P  .001). Two of 5 patients
with ruptured aneurysms had polyarteritis nodosa (40%),
whereas none of 31 patients without ruptured aneurysms
had polyarteritis nodosa (P  .01).
Four patients (11%), 3 men and 1 woman, had symp-
tomatic but nonruptured aneurysms at presentation. Mean
age of patients with symptoms was 49.3 years (range, 20-74
years). Three patients had abdominal pain, and 1 patient
had obstructive jaundice. In this group with symptoms,
fibromuscular dysplasia was present in 1 patient, and 3
patients had concomitant aneurysms.
Methods used for the initial diagnosis are summarized
in Table II. The diagnosis was established at computed
tomography in 14 patients, arteriography in 9 patients, and
ultrasound scanning in 5 patients. In 2 patients HAA was
diagnosed incidentally during abdominal surgery per-
formed because of another condition. In 2 patients rup-
tured HAA was documented during emergent exploration.
One patient died on arrival at the clinic, and the diagnosis
of ruptured HAA was confirmed at autopsy.
Aneurysm characteristics. Anatomic characteristics
of HAA are summarized in Table III. A solitary aneurysm
was present in 33 patients (92%). Multiple hepatic aneu-
rysms were present in 3 patients (8%); 2 of these patients
had ruptured aneurysms at presentation (67%), and both
had polyarteritis nodosa. An extrahepatic aneurysm was
Table II. Method of initial diagnosis
Diagnostic method
Patients
n %
Computed tomography 14 38
Arteriography 9 25
Ultrasound 5 14
Plain radiography 3 8
Incidental finding at
operation
2 6
Operation because of
rupture
2 6
Finding at autopsy 1 3
Table I. Frequency of associated aneurysms
All aneurysms
(n  36 patients)
Asymptomatic
aneurysms
(n  27 patients)
Symptomatic
aneurysms
(n  9 patients)
n % n % n %
Visceral aneurysms 11 31 10 37 1 11
Splenic 7 20 7 23 0
Celiac 4 11 4 13 0
SMA 3 8 2 7 1 11
Gastric 1 3 1 3 0
Gastroduodenal 1 3 1 3 0
Nonvisceral aneurysms 15 42 10 37 5 55
Abdominal aorta 7 20 5 19 2 22
Iliac 6 17 6 20 0
Renal 6 17 3 11 3 33
Thoracic aorta 4 11 3 11 1 11
Carotid 2 6 1 3 1 11
Cerebral 1 3 0 1 11
Family history of aneurysm 1 3 1 3 0
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present in 28 patients (78%). Seven patients (20%) had
mixed aneurysm, with both intrahepatic and extrahepatic
components. Only 1 patient had an isolated intrahepatic
aneurysm. The size and degree of calcification of the aneu-
rysm was documented in 30 patients (83%). Calcification
was noted in 14 patients (47%). Mean HAA diameter was
3.6 cm (range, 1.5-14 cm). Aneurysm diameter (10 cm)
was available for only one ruptured aneurysm. In the symp-
tomatic group, mean HAA diameter was 3.5 cm (range,
2-4.5 cm).
Operative management and outcome. Fourteen pa-
tients (39%) underwent interventions, emergency proce-
dures because of HAA rupture in 3 patients and elective
operations in 11 patients. Mean aneurysm diameter in the
elective group was 5.7 cm (range, 1.5-14 cm). In the group
who underwent elective procedures, 5 patients underwent
repair because of aneurysm size, 4 patients underwent
interventions because of symptoms, and 2 patients under-
went aneurysm repair during abdominal operations per-
formed because of other indications.
The most common procedure was excision of the an-
eurysm with saphenous vein grafting (n  7), followed by
excision with dacron grafting (n  3) and excision and
ligation of the aneurysm (n  2). Successful embolization
was undertaken in 1 patient with a ruptured aneurysm and
1 patient with a symptomatic aneurysm. Operative mortal-
ity was 33% in the group with ruptured aneurysms and 0%
in group who underwent elective surgery. Overall compli-
cation rate was 43% (100% in the rupture group vs 28% in
the elective group). In the rupture group, 1 patient had
multiple organ failure, with gangrenous cholecystitis, and
died; 1 patient had a duodenal leak, intrabdominal abscess,
short gut syndrome, and deep venous thrombosis of the
lower extremities; and 1 patient had a urinary tract infec-
tion. In the elective group, 1 patient had ileus, 1 patient had
acute myocardial infarction and pneumonia, and 1 patient
had pneumonia and catheter sepsis.
Mean follow-up was 47.6 months (range, 1-192
months) in the surgical group. Ten patients (77%) were
alive and well at last follow-up. Three patients died during
the study, 1 each of esophageal carcinoma, ovarian carci-
noma, and ruptured carotid artery aneurysm (initial presen-
tation, ruptured HAA). Graft occlusion was documented in
2 patients with a saphenous vein graft (28.6%) and 1 patient
with a dacron graft (33.3%). In 1 patient with saphenous
vein graft occlusion repeat surgery was performed, with
successful reconstruction with the splenic artery. No risk
factors for graft occlusion were identified.
Nonoperative management and outcome. Nonop-
erative management was chosen in 22 patients (61%). In-
cluded in this group were 2 patients with ruptured HAA at
presentation. One patient was dead on arrival; the other
remained stable, with a contained hematoma due to intra-
abdominal scarring from previous gastric resection, and was
alive at 3-month follow-up. Mean follow-up in this group
was 68.4 months (range, 1-372 months). Data regarding
aneurysm size were available for 18 patients (82%). Four of
these had aneurysms 3 cm or greater in diameter, ie, 3.0,
3.0, 3.5, and 5.0 cm, respectively; in the remaining 14
patients aneurysm diameter was 2 cm or less. Mean diam-
eter of nonruptured HAA was 2.3 cm (range, 1.5-5 cm). Of
the 11 patients with aneurysm size documented at follow-
up, HAA interval growth was noted in 3 patients (27%), ie,
0.8 cm in 34 months, 0.5 cm in 57 months, and 0.3 cm in
70 months, respectively. In all 3 of these patients manage-
ment was nonoperative, because aneurysm diameter was
less than 2.5 cm in 2 patients and because of chronic
lymphocytic leukemia and high operative risk in the other
patient, with aneurysm diameter of 3.5 cm. Three patients
died of causes unrelated to the aneurysm, 1 each of com-
plications of scleroderma (at 132 months), pancreatic can-
cer (at 6 months), and gastrinoma and pulmonary embo-
lism (at 17 months). The remaining patients were alive at
follow-up, with no rupture or other complications related
to the aneurysm.
DISCUSSION
Incidence. Although rare, HAA is the second most
common type of visceral aneurysm after splenic artery an-
eurysm.1,2,8 The true incidence of HAA is unknown. Of
2,091,965 patients seen at the Mayo Clinic between 1980
and 1998, HAA was identified in only 36 patients, yielding
an incidence of 0.002%. HAA represented 12% of all vis-
ceral aneurysms seen at our institutions during that period.
This aneurysm is more common in men.2,5-11 In our study,
most HAA were extrahepatic, a finding consistent with the
reported incidence of 75% to 80%.1-4,6,7,9,10,12,13 Most
HAA are solitary1,8; we found multiple HAA in only 3 of
our patients (8%).
Cause of HAA. The precise cause of HAA remains
unclear. In the early twentieth century, most HAA were
mycotic, with bacterial endocarditis the most frequent
cause.2,12 Today mycotic HAA are seldom seen, because of
earlier antibiotic treatment of infections.9,12 Only 1 patient
in our cohort had a history of infective endocarditis. Several
conditions have been associated with HAA, including ath-
erosclerosis, arterial fibrodysplasia, vasculitis, polyarteritis
nodosa, and systemic lupus erythematosus.1,2,13-15 Rarely
Table III. Anatomic characteristics of HAA
HAA characteristic
All patients
n %
Single 33 92
Multiple 3 8
Extrahepatic 28 78
Intrahepatic 1 3
Extrahepatic and
intrahepatic
7 20
Calcification 14 47
Diameter (cm)
Mean
3.6
Range 1.5-14
HAA, Hepatic artery aneurysms.
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HAA has been associated with disorders such as Takayasu
arteritis, Kawasaki disease, von Recklinghausen neurofibro-
matosis, and Wegener granulomatosis.11,13,16,17 Long-
term oral amphetamine use has been implicated as a possi-
ble cause of HAA.18 Congenital causes of HAA include
Marfan syndrome, Ehlers-Danlos syndrome, Osler-Weber-
Rendu syndrome, and hereditary hemorrhagic
telangiectasia.10,19
Risk for rupture. Previous studies have indicated that
most patients with HAA have symptoms or rupture at
presentation.1 Aneurysm rupture has been reported in 21%
to 80% of all HAA.1-3,6,8,10 In our series the overall inci-
dence of rupture was 14%, lower than that in previous
reports. Furthermore, the incidence of symptomatic aneu-
rysm without rupture in our study was 11%. Most of our
patients (75%) had no asymptomatic aneurysms.
Risk factors associated with rupture of HAA were
poorly defined in the past. Establishment of a relationship
between aneurysm size and risk for rupture has been diffi-
cult because of the rarity of HAA. In our study the smallest
symptomatic HAA was 2 cm in diameter (mean, 3.5 cm).
Size data were available for only one aneurysm in the
rupture group (10 cm). However, rupture of HAA in the 2
cm range has been reported previously.10
An important finding of our study was increased risk for
rupture or symptoms in patients with HAA of nonathero-
sclerotic origin. Of the 9 patients with ruptured or symp-
tomatic HAA at presentation, 3 patients had fibromuscular
dysplasia, 2 patients had polyarteritis nodosa, and 1 patient
had a history of endocarditis. All ruptured aneurysms were
of nonatherosclerotic cause. Therefore there was a 50%
rupture rate in the 10 aneurysms with a cause other than
atherosclerosis. Also, we noted that patients with polyar-
teritis nodosa were significantly more likely to have rup-
tured aneurysms at presentation. Several reports have pre-
viously documented ruptured or symptomatic HAA in
patients with fibromuscular dysplasia, polyarteritis nodosa,
von Recklinghausen neurofibromatosis, and Wegener
granulomatosis.10,11,14,17,20 Another important finding
was that 2 of 3 patients with ruptured aneurysms had
multiple HAA, and both patients had polyarteritis nodosa.
Therefore we do not know whether polyarteritis nodosa or
the presence of multiple aneurysms was the more important
risk factor for rupture. These observations have been re-
ported by others.9,11,14,20 Mortality from rupture in our
study was 40%, consistent with other studies (21%-
43%).1,6,8,21
Indications for treatment. In the past, most authors
have recommended repairing HAA, whether symptomatic
or not, because of the risk for rupture and associated
death.10,12,22,23 While symptomatic and ruptured HAA
require intervention, not all asymptomatic aneurysms war-
rant repair. Our study demonstrated that a selective ap-
proach can be used to manage HAA. On the basis of our
findings, we recommend intervention for all nonatheroscle-
rotic aneurysms and for multiple hepatic aneurysms. Inter-
vention in these subgroups is warranted because of the high
incidence of rupture and symptoms documented in our
study. While no consensus exists regarding size criteria for
intervention in asymptomatic atherosclerotic HAA, we be-
lieve it reasonable to consider surgical repair or emboliza-
tion of aneurysms larger than 2 cm in a patient who is at
reasonable operative risk and has a life expectancy of more
than 2 years.
For asymptomatic atherosclerotic HAA 2 to 5 cm in
diameter in patients with marginal health, treatment op-
tions are more controversial. We did not intervene in 4
patients with aneurysms 3 to 5 cm in diameter, and the
aneurysms did not rupture. This suggests that intervention
in these patients should probably be reserved for those with
aneurysms that enlarge or become symptomatic. However,
treatment decisions in this group of patients are difficult
and must be made on an individual basis, because good data
are lacking. In most patients with aneurysms larger than 5
cm some type of intervention to be undertaken to remove
the risk for rupture.
Treatment options. In 1903 Kehr reported the first
successful ligation of HAA24. Since then, several operative
techniques have evolved for treatment of HAA. Appropri-
ate therapy depends primarily on location of the aneurysm,
presence of collateral flow, operative risk, and clinical sta-
tus. Open surgical treatment options for HAA include
ligation, excision, venous grafting, synthetic grafting, and
hepatic resection.1,2,4,8,13,23 Intrahepatic aneurysms can be
treated with resection, ligation, or embolization.3,10 Lapa-
roscopic surgical techniques may also be useful for ligation
of HAA, inasmuch as this minimally invasive technique has
been used successfully for splenic artery ligation.25
Embolization is an alternative to open repair and has
become increasingly popular.5,15,17,22,26 The technique
has an important role in management of intrahepatic aneu-
rysms and in surgical candidates at high risk. Our limited
experience with embolization in 2 patients was successful.
This technique however, is associated with potential short-
term complications, eg, hepatic ischemia, hepatic abscess,
cholecystitis, and long-term concerns about recanalization
of the aneurysm.15,22,27,28
CONCLUSIONS
Although rare, HAA are at definite risk for rupture. Not
all HAA need intervention, and small (2 cm) HAA may
safely be observed. Risk factors for complications include
multiple HAA or nonatherosclerotic origin, in particular,
polyarteritis nodosa. Patients with symptomatic aneurysm
or any of these risk factors should be considered for inter-
vention. For patients with atherosclerotic HAA greater
than 2 cm, the decision to intervene is more controversial.
It is reasonable to recommend repair of HAA greater than
2 cm in a patient who is at good operative risk and has a life
expectancy greater than 2 years. In patients with marginal
or poor health with a 2 to 5 cm HAA, careful observation
may be warranted, but the decision to intervene must be
made on an individual basis. HAA greater than 5 cm should
generally undergo repair, embolization, or ligation.
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The statistical analysis for this study was performed by
Mr. Jose L. Hernandez from the Section of Biostatistics,
Mayo Clinic Scottsdale.
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